Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Live Ventures Q2 FY2026 Earnings Call - Retail Flooring Slump Drags Results as Steel Impairment Clouds Balance Sheet
Live Ventures reported a sharp divergence in its business units for Q2 FY2026. Retail Entertainment surged 14.8% to $21.2 million, riding strong consumer demand, while Retail Flooring collapsed 26.2% ...
- Consolidated revenue fell 3.8% to $102.9 million, dragged down by a $7.2 million plunge in Retail Flooring.
- Retail Entertainment surged 14.8% to $21.2 million, offsetting weakness elsewhere with strong consumer demand.
- Retail Flooring revenue crashed 26.2% to $20.2 million as new home construction and refurbishment markets weakened.
- +11 more takeaways
Newton Golf Company Q1 2026 Earnings Call - Revenue Dip Masks Strong Demand and OEM Breakthroughs
Newton Golf posted a sharp 18% year-over-year revenue decline in the first quarter of 2026, dropping to $1 million, as the company deliberately paused shipments to overhaul manufacturing processes and...
- Revenue contracted 18% year-over-year to $1 million in Q1 2026, driven by deliberate operational pauses and delayed order fulfillment rather than a collapse in consumer demand.
- Gross margins compressed to 63% from 70% in the prior year quarter due to lower production volumes that reduced fixed cost absorption and manufacturing utilization.
- The company holds a $1.2 million backlog of customer deposits and open sales orders, which management expects to recognize as revenue as fulfillment activities improve in the current quarter.
- +7 more takeaways
Unusual Machines Q1 2026 Earnings Call - Record Revenue Growth and Strategic Battery Acquisition Fuel Supply Chain Dominance
Unusual Machines delivered a blistering Q1 2026, posting $8.1 million in revenue, a 296% year-over-year surge, and $10.3 million in net profit. The company is capitalizing on a severe supply-demand im...
- Revenue surged 296% year-over-year to $8.1 million in Q1 2026, marking the eighth consecutive quarter of record revenue growth.
- Net profit reached $10.3 million for the quarter, with core operations remaining profitable even after excluding $9.5 million in unrealized investment gains.
- The company secured $150 million in a confidential public offering at $17 per share, bringing total working capital to approximately $320 million.
- +7 more takeaways
Shimmick Q1 2026 Earnings Call - Highest Book-to-Bill Ratio Signals Backlog Surge and Margin Expansion
Shimmick delivered a sharp turnaround in the first quarter of 2026, posting consolidated revenue of $88 million and a 12% consolidated gross margin, driven by an 89% year-over-year improvement in core...
- Consolidated revenue of $88 million, with Shimmick core projects generating $88 million and non-core projects dropping to $200,000 from $29 million year-over-year.
- Core Shimmick project gross margin expanded 89% year-over-year to 11%, reflecting improved project selection and execution discipline.
- Total gross margin reached 12%, up from 4% in Q1 2025, driven by the elimination of non-core margin drag and better mix on core work.
- +7 more takeaways
Cibus Q1 2026 Earnings Call - Accelerating Commercial Execution Amid Regulatory Tailwinds
Cibus is pivoting from foundational R&D to aggressive commercial execution in Q1 2026, driven by a $37 million capital raise and a clear shift toward revenue-generating milestones. The company deliver...
- Raised $37 million in gross proceeds via two public offerings in Q1 2026, extending cash runway into Q1 2027.
- Delivered gene-edited rice materials to Interoc in May, a critical step toward the planned 2027 Latin American commercial launch.
- U.S. rice launch delayed to 2029 due to herbicide registration timelines for clethodim; management stresses LATAM is the primary near-term revenue engine.
- +7 more takeaways
Clipper Realty Q1 2026 Earnings Call - Residential Rents Hit Record Highs as Office Asset Struggles
Clipper Realty reported strong residential leasing momentum in Q1 2026, with new free market rents rising over 7% and overall occupancy holding near 99%. The company’s stabilized residential portfolio...
- Residential free market rents rose over 7% on new leases and 5% on renewals, with overall occupancy at 99% across stabilized properties.
- New free market lease rates are at all-time highs, with specific assets like Tribeca House and Clover House averaging $90–$95 per foot.
- AFFO fell to $2.3 million from $8 million year-over-year, driven by a $5.8 million hit from the 250 Livingston Street lease termination and initial lease-up expenses at Prospect House.
- +7 more takeaways
Eton Pharmaceuticals Q1 2026 Earnings Call - Record Sales Surge and Raised Guidance Driven by DESMODA and HEMANGEOL Launches
Eton Pharmaceuticals delivered a record first quarter with product revenue jumping 73% year-over-year to $24.3 million, fueled by strong growth across its existing rare disease portfolio and the initi...
- Product revenue surged 73% year-over-year to $24.3 million in Q1 2026, driven by growth across INCRELEX, ALKINDI SPRINKLE, Galzin, and carglumic acid, plus early sales from DESMODA and HEMANGEOL.
- Full-year revenue guidance was raised to exceed $120 million, up from $110 million, reflecting strong base business performance and early momentum from new product launches.
- Adjusted EBITDA reached $5.7 million, representing a 24% margin, with management reaffirming its target of a 50% adjusted EBITDA margin by 2028.
- +7 more takeaways
Legacy Education Inc. Q3 FY2026 Earnings Call - Record Revenue Growth and Disciplinary Scaling in Healthcare Education
Legacy Education reported a record third quarter for fiscal 2026, with revenue jumping 15% to $21.4 million and adjusted EBITDA rising 12.6% to $4.4 million. The company is capitalizing on structural ...
- Revenue surged 15% year-over-year to $21.4 million in Q3 FY2026, driven by expanded program offerings and improved student retention.
- Adjusted EBITDA climbed 12.6% to $4.4 million, with the adjusted EBITDA margin holding steady at 20.6%.
- Educational services expenses as a percentage of revenue improved by 270 basis points to 51.7%, highlighting significant operating leverage in the academic delivery model.
- +7 more takeaways
Alpha Cognition Inc. Q1 2026 Earnings Call - ZUNVEYL Revenue Surges 40% as Prescriber Adoption Accelerates
Alpha Cognition delivered a strong Q1 2026, with ZUNVEYL revenues jumping 40% quarter-over-quarter to $3.5 million. The company is executing a deliberate commercial expansion, adding a 60-person sales...
- ZUNVEYL revenues reached $3.5 million in Q1 2026, marking a 40% sequential increase and accelerating demand trends into April.
- Prescriber adoption is gaining momentum, with HCP writers growing 23% quarter-over-quarter to 1,060, positioning the company on track for its 2026 goal of approximately 2,000 prescribers.
- Nursing home penetration expanded by 25%, reaching 914 facilities with an 81% repeat order rate, indicating durable adoption and sustained utilization.
- +7 more takeaways
RenovoRx Q1 2026 Earnings Call - Revenue Doubles as Commercial Execution Outpaces Clinical Timeline
RenovoRx delivered its strongest quarter to date, with Q1 2026 revenue doubling to $563,000, driven by a rapid expansion of active commercial centers from eight to sixteen. The company is executing a ...
- Q1 2026 revenue reached $563,000, a 136% increase from Q4 2025 and the company's highest quarterly revenue to date.
- Active commercial cancer centers doubled from eight at year-end 2025 to sixteen as of May 2026, with 32 additional centers in the pipeline.
- RenovoRx reiterated its full-year 2026 revenue guidance of $3 million to $4 million, with Q2 revenue expected to exceed Q1.
- +7 more takeaways